BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 23832923)

  • 21. ACMT Position Statement: Safety Issues Regarding Prescription Fentanyl Products.
    American College of Medical Toxicology
    J Med Toxicol; 2016 Jun; 12(2):211-2. PubMed ID: 26847376
    [No Abstract]   [Full Text] [Related]  

  • 22. Improving drug safety monitoring.
    Karande S; Gogtay NJ; Kshirsagar NA
    Indian Pediatr; 2003 Dec; 40(12):1167-75. PubMed ID: 14722367
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of labeling of foods and pharmaceuticals.
    Viscusi WK
    Annu Rev Public Health; 1994; 15():325-43. PubMed ID: 8054088
    [No Abstract]   [Full Text] [Related]  

  • 24. Overview of the parenteral nutrition use process.
    Boullata JI
    JPEN J Parenter Enteral Nutr; 2012 Mar; 36(2 Suppl):10S-13S. PubMed ID: 22275321
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Consumer understanding of prescription drug information: an illustration using an antidepressant medication.
    Shiffman S; Gerlach KK; Sembower MA; Rohay JM
    Ann Pharmacother; 2011 Apr; 45(4):452-8. PubMed ID: 21427296
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The federal preemption debate in pharmaceutical labeling product liability actions.
    Gross JM; Curry JA
    Tort Trial Insur Pract Law J; 2007; 43(1):35-70. PubMed ID: 18354866
    [No Abstract]   [Full Text] [Related]  

  • 27. The impact of wording in "Dear doctor" letters and in black box labels.
    Weatherby LB; Nordstrom BL; Fife D; Walker AM
    Clin Pharmacol Ther; 2002 Dec; 72(6):735-42. PubMed ID: 12496755
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Specialist societies can assist.
    Bach LA
    Med J Aust; 2007 May; 186(9):483. PubMed ID: 17484714
    [No Abstract]   [Full Text] [Related]  

  • 29. FDA Regulation of Prescription Drugs.
    Gassman AL; Nguyen CP; Joffe HV
    N Engl J Med; 2017 Feb; 376(7):674-682. PubMed ID: 28199811
    [No Abstract]   [Full Text] [Related]  

  • 30. Black box warning contraindicated comedications: concordance among three major drug interaction screening programs.
    Wang LM; Wong M; Lightwood JM; Cheng CM
    Ann Pharmacother; 2010 Jan; 44(1):28-34. PubMed ID: 20040698
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Black box warnings: what do they mean to pharmacists and patients.
    Martin CM; Borgelt L
    Consult Pharm; 2012 Jul; 27(7):482-92. PubMed ID: 22910129
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A call for accurate pharmacogenetic labeling: telling it like it is.
    Burke W; Thummel K
    JAMA Intern Med; 2014 Dec; 174(12):1945-6. PubMed ID: 25317574
    [No Abstract]   [Full Text] [Related]  

  • 33. Lessons from cisapride.
    CMAJ; 2001 May; 164(9):1269, 1271. PubMed ID: 11341130
    [No Abstract]   [Full Text] [Related]  

  • 34. Medication use in pregnancy and the pregnancy and lactation labeling rule.
    Sahin L; Nallani SC; Tassinari MS
    Clin Pharmacol Ther; 2016 Jul; 100(1):23-5. PubMed ID: 27082701
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dual regulatory pharmaceutical labeling schemes; the role of the Federal Preemption Doctrine.
    Fern FH; Bartell L
    Health Matrix; 1987; 5(3):17-23. PubMed ID: 10285381
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Special Interest Group-Sponsored Update in Psychosomatics: Food and Drug Administration Revises Pregnancy and Lactation Drug Labeling.
    Dresner N; Sachdeva J
    Psychosomatics; 2016; 57(4):439-40. PubMed ID: 27283251
    [No Abstract]   [Full Text] [Related]  

  • 37. All Consumer Medication Information Is Not Created Equal: Implications for Medication Safety.
    Monkman H; Kushniruk AW
    Stud Health Technol Inform; 2017; 234():233-237. PubMed ID: 28186047
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of Issues and Future Trends Impacting Drug Safety in South Korea.
    Kim MG; Huh S; Han N; Kim JH; Kim K; Lee E; Kim IW; Oh JM
    Int J Environ Res Public Health; 2019 Sep; 16(18):. PubMed ID: 31547245
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Medication Safety: What Nurses Should Know About Black Box Warnings.
    Leahy LG
    J Psychosoc Nurs Ment Health Serv; 2017 Jun; 55(6):11-15. PubMed ID: 28585662
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Patient-Centered Prescription Drug Label to Promote Appropriate Medication Use and Adherence.
    Wolf MS; Davis TC; Curtis LM; Bailey SC; Knox JP; Bergeron A; Abbet M; Shrank WH; Parker RM; Wood AJ
    J Gen Intern Med; 2016 Dec; 31(12):1482-1489. PubMed ID: 27542666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.